Article Source: msnbc.com
from:msnbc.comDrugmaker Pfizer Inc., which just bought rival Wyeth in October, said Wednesday it will scrap testing of roughly 100 experimental drugs from their combined research operations to focus more resources on its priority areas.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
Colon cancer test may not require laxatives: studyâÂÂBeauty machineâ makes everyone prettyU.S. launches ambitious Alzheimer's plan with research pushScientists build world's first artificial stomachFirst Alzheimer's prevention study launchedGet the scoop on smoothiesThe dirtiest clean places â and how to clean them upWhy isn't HIV testing routine yet?Flesh-eating germ rare, especially for the healthyOklahoma City mayor puts city on a diet
Leave a Comment:
Pfizer is looking ahead and may finish 1st. I hope they find cures for all these problems. R&D is very costly. But they are coming up with life saving drugs.